FDA Investigator Jeremy W Rotton
Jeremy W Rotton has conducted inspections on 15 sites in 7 countries as of 20 Mar 2014. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
15
Last Inspection Date:
20 Mar 2014
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
Japan,
Romania,
France,
United States of America,
Germany,
United Kingdom of Great Britain and Northern Ireland,
India
FDA Investigators that have inspected at least one site in common with Jeremy W Rotton:
Alicia M Mozzachio,
Anh M Lac,
Arie C Menachem,
Azza Talaat,
Barbara I Rogolsky,
Bichsa T Tran,
Bijoy Panicker,
Bonita S Chester,
Breena L D'ambrogi,
Brian D Nicholson,
Brian J Ryan,
Bruce D Broidy,
Bruce H Mccullough,
CDR Donald Ertel,
Charles D Brown,
Charles R Cote, RIC,
Christian D Lynch (CDL),
Christina A Miller,
Christopher D Leach,
Christopher D Rush,
Christopher R Czajka,
Connie L Hannon Rabel,
Cynthia A Harris, MD, RN,
Daniel J Lahar,
David D Anderson, PhD,
David M Beltran,
Debra I Love,
Dr. Barbara D Paul, PhD,
Emilie E Kahn,
Eric M Mueller, PharmD,
Eric M Padgett,
Erika V Butler,
Farhana Khan,
Gerard Pde Leon,
Gina M Hall,
Guerlain Ulysse,
H Ljamilla Selby,
Habacuc V Barrera,
Hala L Selby,
Helen B Ricalde,
Iris C Macinnes,
James M Mason,
James W Plucinski,
Jesse A Vazquez,
Joel D Martinez,
Jose Acruz Gonzalez,
José E Meléndez,
Jose R Hernandez,
Joseph A Morkunas,
Joshua M Adams,
Juan Rjimenez Garcia,
Junho Pak,
Justin A Boyd,
Justine Tomasso,
Kallol Biswas,
Karen C Daugherty,
Karl D Hezel,
Kenneth Nieves,
Kenneth R Merritt,
Kham Phommachanh,
Lance Mde Souza, MBA,
Larkin R Buckalew,
Laura Fontan, MS,
Laurimer Kuilan Torres,
LCDR Debra Emerson,
Leighton Kn Gai,
Linda S Shook,
Lisa Hayka,
Lisa Hornback,
Lisa M Puttonen,
Lorraine N Williams,
Luella J Rossi,
Luis A Solorzano,
Lydia S Chan,
Maotang Zhou, PhD,
Marc R Dickens,
Marcus F Yambot,
Margaret M Annes,
Marion Michaelis,
Mark I Nakano,
Matthew H Hunt,
Matthew K Wong,
Meisha R Sampson,
Meisha Waters,
Michael A Charles,
Michael G Truchan,
Michael R Goga,
Michael R Klapal,
Michelle J Glembin,
Minh D Phan,
Monica Cburgos Garcia,
Mra B Kamberem,
Mra Davism,
Nancy M Espinal,
Nayan J Patel,
Nicholas L Paulin,
Nicholas P Diorio,
Nicole A Lloyd,
Nicole K Trudel,
Nympha V Florendo,
Omotunde O Osunsanmi,
Patricia A Mcilroy,
Patsy J Domingo,
Patty P Kaewussdangkul,
Paul A Bonneau,
Peng Zhou,
Philip M Steele, PhD,
Phillip D Waldron,
Prabhu P Raju,
Rafael Padilla,
Ralph H Vocque,
Ramon E Martinez,
Rebecca Rodriguez,
Rhonda L Dash,
Rita K Kabaso,
Robert J Ham,
Roberta K Smith,
Roy R Rinc,
Russell J Glapion,
Russell K Riley,
Ruth Moore, PhD,
Saijal P Naik,
Saleem A Akhtar,
Sandra A Hughes,
Sandra S Saniga,
Sangeeta M Khurana, PhD,
Shawn E Larson,
Sherrie L Krolczyk,
Shirley J Berryman,
Stefen D Mcmillan,
Stephen D Brown,
Stephen D Eich,
Stephen L Beekman,
Steve P Yost,
Steven B Hertz,
Steven D Kehoe,
Steven Fong, MS, PhD,
Steven M Weinman,
Susan M Jackson,
Susan P Bruederle,
Taichun Qin, PhD,
That Q Dang,
Theresa Kirkham (NMI),
Thomas J Arista,
Thomas N Adjabeng,
Torrance J Slayton,
Toyin B Oladimeji,
Travis M Beard,
Truong Xuan Nguyen (Andy),
Unnee Ranjan,
Vaishali J Patel,
Vlada Matusovsky,
Walden H Lee,
Wayne E Seifert,
Wayne L Jefferson,
William V Millar,
Xiaokuang Lai, PhD,
Yumi J Hiramine
Jeremy W Rotton's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| November, 2012 | FDA 483 | Dynalabs, LLC - Form 483, 2012-11-13 |
| March, 2014 | EIR | Fareva Amboise - EIR, 2014-03-18 |
| September, 2011 | EIR | Medefil, Inc. - EIR, 2011-09-06 |
| March, 2014 | FDA 483 Response | Fareva Amboise - Form 483R, 2014-04-08 |
| September, 2011 | FDA 483 | Medefil, Inc. - Form 483, 2011-09-06 |
| May, 2012 | FDA 483 | Haupt Pharma Wolfratshausen GmbH - Form 483, 2012-05-11 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more